About this episode

The episode discusses the surge in semiconductor stocks, including Intel and memory names, and features an interview with the CEO of Protagonist about a recent drug approval.

Semi stocks soaring, as Intel and memory names jump double digits. How much more this trade can climb, and how our traders are positioning in the chip rip. Plus, Meta’s copyright complications, Coinbase cuts heads as AI shakes up the workforce, and the CEO of biopharma company Protagonist on its recent drug approval and the stock’s big run up over the past year. Fast Money Disclaimer

More episodes of CNBC's "Fast Money"

• Mag7 Hiding Potential Market Trouble… And Expectations Ahead Of Trump-Xi Meeting 5/8/26 · May 8, 2026 · 47 min
• The Health Of The Consumer… And An Old School Options Action On Apple 5/7/26 · May 7, 2026 · 41 min
• Chip Trade Rips… And Global Stocks Rally On Mideast Developments 5/6/25 · May 6, 2026 · 43 min

Explore listener stats, chart rankings, contacts and more on the CNBC's "Fast Money" podcast page.